Home > Funding > Funding Strategy > Funding Strategy (FY01)

Funding Strategy: Fiscal Year 2001

Each fiscal year, after the Fogarty International Center (FIC) receives its appropriation from Congress, FIC staff establish a funding plan based on available resources. In FY 2001, FIC was able to budget $40.4 million for grant awards for fiscal year 2001. These funds are apportioned between our anticipated competing awards of approximately $7.2 million and previously established funding commitments of approximately $33.2 million for our continuing non-competing awards.

During the course of any given year, multiple factors come into play that could affect the implementation of the FIC funding strategy. Please check this website periodically for updates in this regard.

FIC uses several mechanisms to solicit applications for research and research training awards. Requests for Applications (RFAs) and Program Announcements (PAs) are the two chief mechanisms used. RFAs have covered topics such as HIV/AIDS, malaria, emerging infectious diseases, population and health, environmental and occupational health, ecology of infectious disease, biodiversity, maternal and child health, tuberculosis, training for minority students in international research, international research bioethics, and economics and health. The current FIC PAs are the Fogarty International Research Collaboration Award (FIRCA) program, the HIV-AIDS and Related Illnesses Collaboration Award (AIDS-FIRCA) program, and the International Research Scientist Development Award (IRSDA) program. The FIRCA and the AIDS-FIRCA programs use the R03 grant mechanism and are competed three times per year. The International Research Scientist Award (IRSDA) program, which uses the K01 grant mechanism, helps train U.S. scientists in international research, and is competed annually. To review RFAs and PAs that are currently open for application, please refer to the "Programs and Initiatives" section of the FIC website.

FIC employs a variety of funding mechanisms to meet programmatic objectives. These mechanisms include Research Projects (R03 and R01); Cooperative Agreements (U01); Minority International Research Training Grants (T37); International Training Grants in Epidemiology (D43); Educational Projects (R25); and the Research Scientist Development Awards (K01).

The success rate of competing applications generally ranges between 20 to 30 percent depending upon the program, the availability of funds, program relevance, the number of high-quality applications, and the overall number of applications. We fund a large number of initiatives with collaborating funding partners that include other NIH Institutes/Centers, other government agencies, and non-government organizations. In certain programs, the program relevance of our funding partners can also be a factor that affects the selection of grants to be funded. FIC's cost-management plan is to award grants at funding levels and the number of years recommended by the review groups and approved by the FIC Advisory Board, based on the availability of funds.

Non-competing continuation awards will be funded at the recommended total cost level for FY 2001, based on the availability of funds. The recommended total cost level for FY 2001 is reflected on the FY2000 Notice of Grant Award.

If you have questions about the review process, please see the Center for Scientific Review (CSR) website.